Publication
Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome
Hybrid MPO and 5-HT reuptake inhibitors
Jalal Soubhye, Iyas Aldib, Martine Prévost, Betina Elfving, Michel Gelbcke, Manuel Podrecca, Raphaël Conotte, Jean-Marie Colet, Paul G. Furtmüller, Cédric Delporte, Alexandre Rousseau, Michel Vanhaeverbeek, Jean Nève, Christian Obinger, Karim Zouaoui-Boudjeltia, Pierre Van Antwerpen, François Dufrasne
Journal of Pharmacy and Pharmacology, March 2014, Wiley
DOI: 10.1111/jphp.12236